Abstracts by keywords: adherence
Durch die fortschreitende Digitalisierung im Gesundheitswesen erhalten immer mehr Menschen online Zugang zu ihren Gesundheitsdaten. Wichtige Instrumente sind dabei Patientenportale und insbesondere die elektronische Patientenakte (ePA), über die Versicherten Befunde, Arztbriefe und andere Dokumente bereitgestellt werden. Ziel dieses Systems ist es auch, die Einbindung in die eigene Versorgung zu stärken und die Selbstverwaltung zu fördern […]
05.10.2026
Hypertension is responsible for more than seven million deaths worldwide each year, accounting for approximately 13% of all deaths [1]. In Germany, hypertension is diagnosed in more than 60% of people aged 65 and over [2]. Diabetes mellitus (DM) is one of the most common chronic metabolic diseases, affecting around 7% of people in Germany [3]. DM is one of the main risk factors for hypertension [4]. Most hypertension and DM patients require drug therapy, often polypharmacotherapy, to achieve optimal blood pressure and blood glucose control [4,5]. Several classes of drugs are recommended for the treatment of hypertension [4] and DM [5]. However, adherence to these therapies is still a common problem [6, 7]. The current coronavirus pandemic is having a major impact on healthcare systems around the world. Maintaining adherence in patients with chronic diseases during a pandemic can become a major challenge for physicians and pharmacies [8]. There is a risk that good care for Covid-19 patients could negatively impact the care of around 19 million patients with hypertension [9] and over 7 million patients with type 2 diabetes mellitus [10]. To date, no studies have been published on prescriptions of antihypertensive and antidiabetic medications or patient adherence to these therapies during the pandemic. It is to be expected that people are less likely to be adherent to therapy during this time. The aim of this study was to examine the development of the number of patients who received cardiovascular or diabetic medications from pharmacies in the first quarter of 2020.
28.07.2020
Patient coaching as an innovative service in the healthcare system serves the purpose of promoting compliance, adherence, active participation and self-management of patients in coping with their illness, taking individual preferences into account. In this article, based on a definition of patient coaching, its necessity is derived from the high non-compliance or non-adherence rate, particularly among chronically ill and multimorbid patients. These are patients who require approximately 4/5 of all services provided by the health system. Compliance and adherence are described in terms of their importance as descriptive markers for the quality of patient cooperation in the treatment process. It should be noted that they should also be questioned with regard to their different causes (e.g. system-related, communication-related, individual/preference-related) so that a targeted and promising intervention can result in individual cases.
01.08.2009
Health management services are knowledge-based services. They can be used in different care settings and in different phases of the indication-specific disease progression. A distinction is made between selective, periodic to sequential and continuous HMS interventions. The instruments start with simple reminder or e-mail educational services (Infocept), lead through more data- and technology-driven call centers or risk assessments to personnel-intensive offers such as case or disease management programs. In the future, personal health coaching and behavior modification will become more important if you really want to achieve sustainability. The costs for HMS instruments and programs range between 5 euros and 2,000 euros per intervention or year. The benefit lies in improved medical outcomes. Financing can be provided by cost bearers, service providers, product providers, additional insurance or personal contributions.